公开(公告)号：US11747345B2

公开(公告)日：2023-09-05

申请号：US16487335

申请日：2018-02-19

Applicant: The Board of Regents of the University of Texas System

Inventor： David E. Gerber ,  Edward Wakeland ,  Quan Li ,  Saad Khan ,  Jason Y. Park ,  Xin Luo ,  Yang Xie

IPC: G01N33/68 ,  C07K16/28

CPC classification number: G01N33/6854 ,  C07K16/2818 ,  G01N2800/24

Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.

公开(公告)号：US20240077496A1

公开(公告)日：2024-03-07

申请号：US18338997

申请日：2023-06-21

Applicant: The Board of Regents of The University of Texas System

Inventor： David E. Gerber ,  Edward Wakeland ,  Quan Li ,  Saad Khan ,  Jason Y. Park ,  Xin Luo ,  Yang Xie

IPC: G01N33/68 ,  C07K16/28

CPC classification number: G01N33/6854 ,  C07K16/2818 ,  G01N2800/24

Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.